Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:651-657
Published online before print January 3, 2008, doi: 10.1161/ATVBAHA.107.159533
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Additional Materials
Right arrow All Versions of this Article:
28/4/651    most recent
ATVBAHA.107.159533v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Luo, B.
Right arrow Articles by McClain, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luo, B.
Right arrow Articles by McClain, D. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*GLUCOSE
Related Collections
Right arrowRelated Article
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:651.)
© 2008 American Heart Association, Inc.


Integrative Physiology/Experimental Medicine

Protein Modification by O-Linked GlcNAc Reduces Angiogenesis by Inhibiting Akt Activity in Endothelial Cells

Bai Luo; Yudi Soesanto; Donald A. McClain

From the Division of Endocrinology, University of Utah School of Medicine, Salt Lake City, Utah.

Correspondence to Dr Donald McClain, Division of Endocrinology, University of Utah, Salt Lake City, UT 84132. E-mail donald.mcclain{at}hsc.utah.edu

Objective— Glucose flux through the hexosamine biosynthesis pathway (HBP) has been implicated in the development of diabetic vascular complications. O-linked N-acetylglucosamine (O-GlcNAc) modification on protein is the major mechanism mediating the actions of the HBP. Impaired angiogenesis is well-recognized in diabetes; however, the mechanisms are not completely defined. Here, we investigated the role of protein O-GlcNAc modification in angiogenesis.

Methods and Results— In a mouse aortic ring assay, elevated O-GlcNAc levels induced by high-fat diet, streptozotocin-induced diabetes, or in vitro glucosamine treatment were associated with impaired angiogenesis. In cultured human umbilical vein endothelial cells and EA.hy926 endothelial cells, glucosamine increased protein O-GlcNAc modification and inhibited cell migration and capillary-like structure formation. Conversely, removal of O-GlcNAc by adenoviral-mediated overexpression of O-GlcNAcase improved these steps of angiogenesis. Also, high concentrations of glucose reduced capillary-like structure formation of human umbilical vein endothelial cells. Akt was recognized by an O-GlcNAc specific lectin, and glucosamine increased the amounts of Akt protein in these lectin precipitates. Increased glycosylation paralleled reduced Akt activity in endothelial cells.

Conclusion— These results suggest that elevated protein O-GlcNAc modification through the HBP impairs angiogenesis in endothelial cells, possibly by inhibiting Akt signaling.

Angiogenesis is impaired in diabetes. Here, we demonstrate that elevated O-GlcNAc levels inhibit vascular sprouting from mouse aortic rings and migration and capillary-like structure formation of endothelial cells. Akt signaling plays a key role in this O-GlcNAc–mediated angiogenesis regulation.


Key Words: hexosamine • angiogenesis • O-GlcNAc • endothelial cells • Akt


Related Article:

More Sugar, Less Blood Vessels: Another Piece in the Puzzle of Increased Cardiovascular Risk in Diabetes
Christian Rask-Madsen and George L. King
Arterioscler Thromb Vasc Biol 2008 28: 608-610. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
D. R. D'Souza, M. M. Salib, J. Bennett, M. Mochin-Peters, K. Asrani, S. E. Goldblum, K. J. Renoud, P. Shapiro, and A. Passaniti
Hyperglycemia Regulates RUNX2 Activation and Cellular Wound Healing through the Aldose Reductase Polyol Pathway
J. Biol. Chem., July 3, 2009; 284(27): 17947 - 17955.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. Laczy, B. G. Hill, K. Wang, A. J. Paterson, C. R. White, D. Xing, Y.-F. Chen, V. Darley-Usmar, S. Oparil, and J. C. Chatham
Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system
Am J Physiol Heart Circ Physiol, January 1, 2009; 296(1): H13 - H28.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. A. Ngoh and S. P. Jones
New Insights into Metabolic Signaling and Cell Survival: The Role of {beta}-O-Linkage of N-Acetylglucosamine
J. Pharmacol. Exp. Ther., December 1, 2008; 327(3): 602 - 609.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
Y. A. Soesanto, B. Luo, D. Jones, R. Taylor, J. S. Gabrielsen, G. Parker, and D. A. McClain
Regulation of Akt signaling by O-GlcNAc in euglycemia
Am J Physiol Endocrinol Metab, October 1, 2008; 295(4): E974 - E980.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Rask-Madsen and G. L. King
More Sugar, Less Blood Vessels: Another Piece in the Puzzle of Increased Cardiovascular Risk in Diabetes
Arterioscler Thromb Vasc Biol, April 1, 2008; 28(4): 608 - 610.
[Full Text] [PDF]